https://www.selleckchem.com/JAK.html
difficult-to-treat infections. IMP-type carbapenemases are rarely detected in Europe and limited information is available to guide the treatment of infections caused by carbapenemase-producing Enterobacterales (CPE) producing these carbapenemases. Accurate antimicrobial susceptibility testing (AST) results are essential for optimal antibiotic management. Here we report discrepancies in AST of IMP-producing Enterobacterales (IMP-CPE) complicating the management of severe sepsis. Antimicrobial susceptibilities were analysed by in-house VITEK® 2, Etest
Like
Comment
Share
